EVI together with partners and sponsors from China organised a two-day vaccine collaboration workshop from 9-10 November in Chengdu, China.

Funding from EDCTP will allow testing of a novel whole-cell inactivated oral vaccine in clinical trials in Europe and Africa The European...

The ZIKAVAX consortium announced today the initiation of a Phase 1 clinical trial of a second-generation Zika vaccine. The vaccine...

Horizon2020 award to consortium will support the testing of an innovative live attenuated vaccine in phase I clinical trials in Europe...

We invite you to read more about how we advanced the development of urgently needed vaccines and other activities we undertook in 2018.

Join the SENET project´s Group Meetings and have a say within the health research and innovation landscape between the EU and China!

“Zero Malaria Starts with Me”

This project aims to advance a new asexual blood-stage malaria vaccine candidate, based on the PfRipr5 protein of the malaria parasite....

This work paved the way for the clinical development of a vaccine against placental malaria.

EVI supports new EC-funded project that aims to strengthen international research and innovation cooperation between China and the EU

TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines.

CEPI awards contract worth up to US$ 31 million to develop vaccine against Nipah virus.

Workshop will concentrate on latest advances in non-invasive imaging technologies.

3rd Call for TRANSVAC Training Modules now advertised.

The Multi-Stage Malaria Vaccine Consortium (MMVC) offers 3 PhD Fellowships in Malaria Research.

EVI-supported project publishes first clinical results for vaccine candidate to prevent pregnancy-associated malaria.

European Commission highlights that EU-funded TRANSVAC2 project.

Deadline for submission: 7 March 2019, 16:00 (GMT)

New article published on in npj Vaccines

The annual meeting of the GHIT-funded SEmalvac2 and SEmalvac projects was successfully held on 29-30 May in Ouagadougou, Burkina Faso.

The European and African partners of the EDCTP-funded project PREV_PKDL met at the University of York (United Kingdom) on 07-08 June 2018.

EVI and Processing personal data on the basis of the EU/EEA General Data Protection Regulation.

Phase II clinical trials in Sudan of a therapeutic vaccine to prevent post kala azar dermal leishmaniasis to be supported by EDCTP.